News
Keep up-to-date with the latest news from the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife.
Keep up-to-date with the latest news from the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife.
Showing 12 results
SGLT-2 inhibitors like Jardiance and GLP-1 drugs like Ozempic are associated with slower frailty progression in older adults with type 2 diabetes.
National analysis shows long-term use of anticoagulants after an unprovoked blood clot offers major health benefits, despite increase in bleeding risk.
Medicare data may miss the majority of opioid use after hospital discharge in skilled nursing facilities, raising concerns for patient safety and care.
Prolonged benzodiazepine use puts older adults at risk of falls, cognitive decline, and dependence.
Continued prevalence of persistent delirium warrants further delirium management efforts.
Early findings indicate the feasibility, safety, and potential cognitive benefits of Dasatinib and Quercetin therapy.
Focuses on stroke prevention, early rhythm control, and reassessing aspirin as a preventive.
She succeeds Lewis Lipsitz, MD, who continues as director of the Hinda and Arthur Marcus Institute for Aging Research and chief academic officer at Hebrew SeniorLife.
Findings showed a lower risk of fall-related injuries.
Authors advocate for additional research to improve decision-making before initiating lecanemab